Phathom Pharmaceuticals, Inc. (PHAT) › Cash & EquivalentsPhathom Pharmaceuticals, Inc. (PHAT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $879.0K2019: $243.76M2020: $287.50M2021: $183.26M2022: $155.38M2023: $381.39M2024: $297.26M2025: $129.97M$129.97M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$129.97M-56.3%2024$297.26M-22.1%2023$381.39M+145.5%2022$155.38M-15.2%2021$183.26M-36.3%2020$287.50M+17.9%2019$243.76M+27632.1%2018$879.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share